DR. PETER W. COHEN M.D.
Prescription History 1962462721
Psychiatry & Neurology - Psychiatry in Arlington, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PETER W. COHEN M.D., an active Psychiatry specialist practicing in Arlington, MA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 62 documented patient claims. Among these therapy options, the most frequently utilized medication is Haloperidol Decanoate, which accounts for 17 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Haloperidol Decanoate | 17 | $45.83 | ▼ Less than typical |
About Haloperidol Decanoate: This medication is used to treat a certain mental/mood disorder (schizophrenia). Show more ▾ Haloperidol decanoate is a long-acting form of haloperidol. It may be used by people who have trouble remembering to take medication every day. Haloperidol belongs to a class of drugs known as antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) In 2024, this provider wrote 17 Medicare prescriptions for Haloperidol Decanoate, about 64% of the volume of the typical Massachusetts prescriber of this medication (26.4). Medicare paid an average of $45.83 per fill, versus $37.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 399 Days of Medication total across all patients in 2024 | |||
| Benztropine Mesylate | 16 | $15.51 | ▼ Less than typical |
About Benztropine Mesylate: Benztropine is used to treat symptoms of Parkinson's disease or involuntary movements due to the side effects of certain psychiatric drugs (antipsychotics such as chlorpromazine/haloperidol). Show more ▾ Benztropine belongs to a class of medication called anticholinergics that work by blocking a certain natural substance (acetylcholine). This helps decrease muscle stiffness, sweating, and the production of saliva, and helps improve walking ability in people with Parkinson's disease. Anticholinergics can stop severe muscle spasms of the back, neck, and eyes that are sometimes caused by psychiatric drugs. It can also decrease other side effects such as muscle stiffness/rigidity (extrapyramidal signs-EPS). It is not helpful in treating movement problems caused by tardive dyskinesia and may worsen them. Benztropine should not be used by children younger than 3 years. A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine. In 2024, this provider wrote 16 Medicare prescriptions for Benztropine Mesylate, about a third of the volume of the typical Massachusetts prescriber of this medication (48.7). Medicare paid an average of $15.51 per fill, versus $12.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 386 Days of Medication total across all patients in 2024 | |||
| Lorazepam | 15 | $7.42 | ▼ Less than typical |
About Lorazepam: This medication is used to treat anxiety. Show more ▾ Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA). A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. In 2024, this provider wrote 15 Medicare prescriptions for Lorazepam, about a quarter of the volume of the typical Massachusetts prescriber of this medication (59.7). Medicare paid an average of $7.42 per fill, versus $6.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 324 Days of Medication total across all patients in 2024 | |||
| Haloperidol | 14 | $44.28 | ▼ Less than typical |
About Haloperidol: This medication is used to treat certain mental/mood disorders (such as schizophrenia, schizoaffective disorders). Show more ▾ Haloperidol is also used to treat uncontrolled movements and outbursts of words/sounds related to Tourette's syndrome. It is also used by hyperactive children for severe behavior problems when other treatments or medication have not worked. Haloperidol belongs to a class of drugs known as antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) In 2024, this provider wrote 14 Medicare prescriptions for Haloperidol, about a third of the volume of the typical Massachusetts prescriber of this medication (36.8). Medicare paid an average of $44.28 per fill, versus $24.73 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 379 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. PETER W. COHEN M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Psychiatry prescribing approach at this Arlington, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
